0001140361-16-051872.txt : 20160211 0001140361-16-051872.hdr.sgml : 20160211 20160211193445 ACCESSION NUMBER: 0001140361-16-051872 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160209 FILED AS OF DATE: 20160211 DATE AS OF CHANGE: 20160211 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Raptor Pharmaceutical Corp CENTRAL INDEX KEY: 0001070698 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 860883978 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-408-6200 MAIL ADDRESS: STREET 1: 7 HAMILTON LANDING STREET 2: SUITE 100 CITY: NOVATO STATE: CA ZIP: 94949 FORMER COMPANY: FORMER CONFORMED NAME: Raptor Pharmaceutical Corp. DATE OF NAME CHANGE: 20090929 FORMER COMPANY: FORMER CONFORMED NAME: TorreyPines Therapeutics, Inc. DATE OF NAME CHANGE: 20061003 FORMER COMPANY: FORMER CONFORMED NAME: AXONYX INC DATE OF NAME CHANGE: 19990303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Julie CENTRAL INDEX KEY: 0001557928 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-25571 FILM NUMBER: 161413651 MAIL ADDRESS: STREET 1: C/O RAPTOR PHARMACEUTICAL CORP STREET 2: 9 COMMERCIAL BLVD, SUITE 200 CITY: NOVATO STATE: CA ZIP: 94949 4 1 doc1.xml FORM 4 X0306 4 2016-02-09 0 0001070698 Raptor Pharmaceutical Corp RPTP 0001557928 Smith Julie C/O RAPTOR PHARMACEUTICAL CORP. 7 HAMILTON LANDING, SUITE 100 NOVATO CA 94949 1 1 0 0 President and CEO Common Stock 2016-02-09 4 A 0 64179 0 A 102129 D Stock options (right to buy) 3.74 2016-02-09 4 A 0 240595 0 A 2026-02-09 Common Stock 240595 240595 D Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU, subject to continued service. One-fourth of the total RSUs vest annually, beginning on the first anniversary of the grant date. The options have a four year vesting schedule, vesting 1/48th per month following the grant date. /s/ Mark Jones, Raptor Pharmaceutical Corp., Attorney-in-Fact 2016-02-11